Seeing Is Believing
Currently out of the existing stock ratings of Sriharsha Pappu, 15 are a BUY (65.22%), 5 are a HOLD (21.74%), 3 are a SELL (13.04%).
Analyst Sriharsha Pappu, currently employed at HSBC, carries an average stock price target met ratio of 59.76% that have a potential upside of 18.86% achieved within 346 days.
Sriharsha Pappu’s has documented 45 price targets and ratings displayed on 7 stocks. The coverage is on the Basic Materials sector.
Most recent stock forecast was given on SSL, Sasol Ltd at 24-Feb-2023.
Analyst best performing recommendations are on DNA (GINKGO BIOWORKS HOLDINGS).
The best stock recommendation documented was for DNA (GINKGO BIOWORKS HOLDINGS) at 9/21/2021. The price target of $14 was fulfilled within 28 days with a profit of $2.3 (19.66%) receiving and performance score of 7.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$0.65
$0.51 (364.29%)
$3.35
1 years 5 months 26 days ago
(18-May-2023)
2/2 (100%)
$0.06 (10.17%)
10
Buy
$1.25
$1.2 (2400.00%)
$19
1 years 6 months 4 days ago
(10-May-2023)
3/4 (75%)
$2.13 (47.39%)
21
Buy
$5
$4.86 (3471.43%)
$30
1 years 7 months 28 days ago
(16-Mar-2023)
7/10 (70%)
$3.68 (278.79%)
819
Hold
$2
$1.86 (1328.57%)
$2.5
1 years 10 months 10 days ago
(03-Jan-2023)
1/2 (50%)
$0.55 (37.93%)
2
Hold
2 years 4 days ago
(09-Nov-2022)
1/2 (50%)
$7.57 (43.43%)
391
What Year was the first public recommendation made by Sriharsha Pappu?